CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
批准号:
2091960
负责人:
MICHAEL B LILLY
金额:
$9.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1997-02-28
关键词:
antisense nucleic acid apoptosis biological signal transduction colony stimulating factor cytokine gene expression hematopoietic growth factor myelogenous leukemia neoplasm /cancer immunology phenotype plasmids polymerase chain reaction recombinant proteins tissue /cell culture transfection western blottings
中文摘要
描述:(改编自申请人的摘要)本申请寻求
以表征增殖信号通路中的关键步骤,
在原始骨髓细胞中由GM-CSF激活相关细胞因子。在
至少有一些髓性白血病病例可能是由于过度活动引起的
这样的信号通路。 确定关键或独特的步骤,
这种级联反应可能允许开发药物干预,
专门破坏这些通路。 这个问题的具体假设
应用是PIM-1基因工程,一种33 kD
丝氨酸/苏氨酸激酶,是有效增殖所必需的,
通过GM-CSF和相关受体进行信号传导。 申请者还
假设pim-1的表达是一个特异性的指标,
激活这些途径。 该假设将由以下人员进行调查:
构建允许过表达或阻断的细胞系统
pim-1活性。 因子依赖性骨髓细胞系将是
用质粒构建体或逆转录病毒构建体转染,
pim-1基因产物的自主表达。然后,
检查是否存在非因子依赖性生长,分化受损,
抑制细胞凋亡和同型聚集。 相似细胞系
将利用含有反义PIM-1构建体的质粒产生
以抑制内源性PIM-1基因的活性。 这些细胞将
研究了对GM-CSF和相关细胞因子及其
分化倾向。
英文摘要
DESCRIPTION: (Adapted from applicant's abstract)This application seeks
to characterize critical steps in the proliferative signalling pathways
activated by GM-CSF in related cytokines in primitive myeloid cells. At
least some cases of myeloid leukemia likely result from over activity
of such signal pathways. Identification of critical or unique steps in
such cascades may allow development of pharmacologic interventions to
specifically disrupt these pathways. The specific hypothesis of this
application is that expression of the pim-1 gene project, a 33 kd
serine/threonine kinase, is necessary for effective proliferative
signalling through GM-CSF and related receptors. The applicant further
hypothesizes that pim-1 expression serves as a specific indicator of
activation of such pathways. The hypothesis will be investigated by
constructing cell systems which allow for the over expression or blockade
of pim-1 activity. Factor-dependent myeloid cell lines will be
transfected with plasmid constructs or retroviral constructs to allow
autonomous expression of the pim-1 gene product.These lines will then
be examined for factor- independent growth, impaired differentiation,
inhibition of apoptosis and homotypic aggregation. Similar cell lines
will be created utilizing plasmids containing antisense pim-1 constructs
to inhibit activity of the endogenous pim-1 gene. These cells will be
studied for the responsiveness to GM-CSF and related cytokines and their
propensity to differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 1 Bioassay-guided Trial of Lycopene and Docetaxel for Prostate Cancer
-
批准号:8723134
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
-
批准号:9242567
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
-
批准号:8831452
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
Phase 1 Bioassay-guided Trial of Lycopene and Docetaxel for Prostate Cancer
-
批准号:8512436
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:7391006
-
项目类别:
-
资助金额:$3.09万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:6783914
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:6892356
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188842
-
项目类别:
-
资助金额:$4.21万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
-
批准号:2091961
-
项目类别:
-
资助金额:$10.51万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
-
批准号:2091959
-
项目类别:
-
资助金额:$10.19万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188844
-
项目类别:
-
资助金额:$8.8万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALLING IN MYELOID LEUKEMIAS
-
批准号:3509555
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188843
-
项目类别:
-
资助金额:$12.65万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188839
-
项目类别:
-
资助金额:$14.11万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177712
-
项目类别:
-
资助金额:$10.89万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177711
-
项目类别:
-
资助金额:$10.13万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177710
-
项目类别:
-
资助金额:$10.39万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
Murine model of chronic prostatitis
-
批准号:7547700
-
项目类别:
-
资助金额:$1.56万
-
财政年份:--
-
负责人:MICHAEL B LILLY
-
依托单位:
A Phase 1b Trial of Oligomeric Procyanidin Complex in Combination with Metformin for Reduced AGE Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
-
批准号:9419085
-
项目类别:
-
资助金额:$7.45万
-
财政年份:--
-
负责人:MICHAEL B LILLY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: